This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • PROfound
      • VISION Trial
    • mHSPC
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • PSMA PET Imaging
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Bladder Cancer
          • Bladder Cancer
            Ashish Kamat, MD
          • Advanced Bladder Cancer
            Petros Grivas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
          • Kidney Cancer Today
            Sumanta (Monty) Kumar Pal, MD
            Jaime Landman, MD
      • Prostate Cancer
        • Advanced Prostate Cancer
          Alicia Morgans, MD, MPH
        • CRPC with Bone Metastases
          Rana R. McKay, MD
        • Imaging Center
          Phillip Koo, MD
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • mHSPC
          Alicia Morgans, MD, MPH
        • nmCRPC
          Alicia Morgans, MD, MPH
        • PSMA-Targeted Therapy
      • Translational Prostate Cancer
        • Women in Science
          Andrea Miyahira, Ph.D
        • Health Policy
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • TESTICULAR, PENILE & RARE GU MALIGNANCIES
        • Testicular, Penile, and Rare GU Malignancies
    • Pelvic Health & Reconstruction
      • Bladder Health
        Diane K. Newman, DNP, ANP-BC, FAAN
      • Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
        Stephen R. Kraus, MD
      • Urologic Catheters (Includes CAUTI)
        Diane K. Newman, DNP, ANP-BC, FAAN
  • Videos
    • Exclusives
      • Conferences
      • Exclusive Collaborations
      • Independent Education
      • Covid-19
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Pelvic Health & Reconstruction
      • Endourology
      • Testicular Cancer
      • Health Policy in Urological Diseases
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
    • Trials in Progress
      • DORA - PCCTC
      • IRONMAN - PCCTC
      • PROMISE - PCCTC
      • SPLASH Trial
      • Oral EPI-7386
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SUO 2022
      • ASCO GU 2023
      • EAU 2023
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Recent Abstracts
  3. Urologic Oncology
  4. Prostate Cancer

Conferences

Recent Abstracts
WMSM 2012 - Male cancers and specific requests for sexual care: Lessons for daily practice based on 3 prospective surveys in an outpatient urology clinic in public hospital - Poster September 8, 2012
WMSM 2012 - Cancer and sexuality: A specific survey in 320 health care professionals in order to specify the perceived needs for information or training - Session Highlights September 7, 2012
WMSM 2012 - Sexual dysfunction in the prostate cancer patient - Session Highlights September 6, 2012
WMSM 2012 - Determining the optimal erectile function domain score cutoff after radical prostatectomy (RP) - Session Highlights September 6, 2012
WMSM 2012 - Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction following prostate biopsy - Session Highlights September 6, 2012
WMSM 2012 - Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men one year following surgical treatment for localized prostate cancer - Session Highlights September 5, 2012
WMSM 2012 - Nitric oxide-releasing polymeric microspheres as a therapy for erectile dysfunction - Session Highlights September 5, 2012
ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Slide Presentation June 25, 2012
ASCO 2012 - Effect of neoadjuvant abiraterone acetate plus leuprolide acetate on PSA, pathological complete response (pCR), and near pCR in localized high-risk prostate cancer: Results of a randomized phase 2 study - Editor's Commentary June 25, 2012
ASCO 2012 - An interview with Charles J. Ryan, MD: Presentation of the New Paradigms for Hormone Therapy in Prostate Cancer, clinical symposium at the ASCO 2012 Annual Meeting June 22, 2012
AUA 2012 - Durable results and possible restitution of normal urethra following circumferential laser vaporization of the urethral strictures - Slide Presentation May 31, 2012
2012 ASCO Annual Meeting press program announced May 31, 2012
AUA 2012 - European Randomized Study of Screening for Prostate Cancer (ERSPC): An update after 11 years of follow-up - Slide Presentation May 30, 2012
AUA 2012 - Making sense of all the new options: Pragmatic considerations in CRPC - Slide Presentation May 30, 2012
AUA 2012 - The absence of goal setting in the dialogue between metastatic prostate cancer (mCRPC) patients and their physicians: An opportunity for shared decision making? - Another Perspective May 30, 2012
AUA 2012 - Does long-term aspirin use lower serum PSA levels? – Results from the Duke Prostate Center - Session Highlights May 30, 2012
AUA 2012 - Unilateral prostate cancer: Analysis of predictors in search and Duke Prostate Center databases - Session Highlights May 30, 2012
AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD May 30, 2012
AUA 2012 - Neurostimulation treatment for overactive bladder: An evaluation of cost effectiveness data - Slide Presentation May 29, 2012
AUA 2012 - Neurostimulation treatment for overactive bladder: An evaluation of cost effectiveness data - Abstract May 29, 2012
Page 487 of 507
  • Start
  • Prev
  • 482
  • 483
  • 484
  • 485
  • 486
  • 487
  • 488
  • 489
  • 490
  • 491
  • Next
  • End
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2023 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free